Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Audio-Described Menopause Education Program in Visually Impaired Women

17. august 2026 opdateret af: İlknur Münevver Gönenç, Ankara University

The Effect of Education Provided Through Audio Description Method on Menopause Knowledge and Menopausal Symptoms in Visually Impaired Women: Randomized Controlled Trial

This randomized controlled trial was conducted to evaluate the effect of an audio-described menopause education program on menopause knowledge and menopausal symptoms in women with visual impairment. A total of 46 women who were members of the Ankara Branch of the Altı Nokta Blind Association were randomly assigned to either an intervention group (n=23) or a control group (n=23). The intervention group received an accessible menopause education program, while the control group did not receive the intervention during the study period. Outcomes included menopause knowledge and menopausal symptom severity, assessed using standardized measurement tools.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

This study was designed as a randomized controlled trial in accordance with CONSORT guidelines. It aimed to determine the effectiveness of an audio-described menopause symptom and awareness education program for women with visual impairment on menopause knowledge and menopausal symptoms.

The study sample consisted of 46 women who were members of the Ankara Branch of the Altı Nokta Blind Association. Participants were randomly allocated in a 1:1 ratio to either the intervention group (n=23) or the control group (n=23).

Data were collected using a demographic information form, the Menopause Knowledge Scale, and the Menopause Rating Scale. The intervention group received an audio-described educational program designed to improve accessibility for women with visual impairment, while the control group did not receive the intervention during the study period.

Statistical analyses included descriptive statistics, Fisher-Freeman-Halton Exact test, Pearson chi-square test, Cronbach's alpha reliability analysis, assessment of skewness and kurtosis for normality, Pearson correlation analysis, independent samples t-test, and analysis of covariance (ANCOVA). Statistical significance was set at p < 0.05.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

46

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Tyrkiet (Türkiye)
    • Altindağ
      • Ankara, Altindağ, Tyrkiet (Türkiye), 06250
        • Ankara University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Being a member of the Ankara Branch of the Altı Nokta Blind Association,
  • Being a woman with visual impairment (congenital or acquired),
  • Being female,
  • Being between 40 and 60 years of age,
  • Being able to speak Turkish,
  • Having no additional communication problems other than visual impairment,
  • Having experienced at least 12 months of amenorrhea (STRAW+1 criteria).

Exclusion Criteria:

  • Refusal to participate in the study,
  • Previous participation in a structured menopause-related education program,
  • Use of pharmacological treatment for the management of menopausal symptoms,
  • Use of non-pharmacological methods for menopausal symptom management (e.g., yoga, aromatherapy, phytotherapy, etc.),
  • Surgical menopause,
  • Having additional disabilities other than visual impairment (hearing, intellectual, or physical disabilities).

Withdrawal / Discontinuation Criteria

  • Initiation of any pharmacological or non-pharmacological intervention aimed at reducing menopausal symptoms during the study period,
  • Non-adherence to the study protocol,
  • Voluntary withdrawal from the study.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Audio description-based menopause education program
Participants in this arm received an audio-described menopause education program designed for women with visual impairment. The intervention aimed to improve menopause knowledge and reduce menopausal symptom-related difficulties. The educational content was delivered in an accessible format tailored to participants' needs. Outcomes were assessed using standardized measurement tools.
Adfærdsmæssigt: Audio-Described Menopause Education Program
This intervention consisted of a structured audio-described menopause education program developed for women with visual impairment. The program provided accessible information about menopause, menopausal symptoms, and symptom management strategies to improve knowledge and awareness.
Ingen indgriben: Standard of care
Participants in this arm did not receive the audio-described menopause education program during the study period. They continued with their usual daily life without any structured educational intervention related to menopause. Outcomes were assessed at the same time points using standardized measurement tools.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Menopause Knowledge
Tidsramme: Measured at three time points: baseline (pre-test), immediately after the intervention (T1), and 1 month post-intervention (T2).
To assess changes in menopause knowledge following the audio-described menopause education program. The total score of the "Menopause Knowledge Scale" ranges from 14 to 70, with higher scores indicating a higher level of overall knowledge about menopause. Similarly, higher scores on the General Menopause Knowledge subscale (5-25) and the Knowledge of Menopausal Symptoms and Management subscale (9-45) indicate greater knowledge in the respective domains.
Measured at three time points: baseline (pre-test), immediately after the intervention (T1), and 1 month post-intervention (T2).
Menopausal Symptom Severity
Tidsramme: Measured at three time points: baseline (pre-test), immediately after the intervention (T1), and 1 month post-intervention (T2).
To evaluate changes in menopausal symptom severity following the audio-described menopause education program. The Menopause Rating Scale was used to assess the severity of menopausal symptoms.The total score of the scale ranges from 0 to 44. Higher total scores indicate greater severity of menopausal symptoms and a more negative impact on quality of life.
Measured at three time points: baseline (pre-test), immediately after the intervention (T1), and 1 month post-intervention (T2).

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Ankara University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

15. februar 2025

Primær færdiggørelse (Faktiske)

15. juli 2025

Studieafslutning (Faktiske)

15. juli 2025

Datoer for studieregistrering

Først indsendt

3. juli 2026

Først indsendt, der opfyldte QC-kriterier

17. august 2026

Først opslået (Faktiske)

19. august 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

19. august 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. august 2026

Sidst verificeret

1. august 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • Ankara University Thesis

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

De-identified participant data, including baseline characteristics and outcome measures, will be shared. No identifiable personal data will be included.

IPD-delingstidsramme

De-identified individual participant data will be available beginning 6 months after publication of the study results and will remain available for 5 years.

IPD-delingsadgangskriterier

Access to individual participant data and supporting documents will be granted to qualified researchers who submit a methodologically sound research proposal. Requests must be approved by the principal investigator or study sponsor. Data will be provided for non-commercial academic research purposes only. All data will be de-identified, and no personally identifiable information will be shared. Data will be shared via secure electronic transfer upon approval.

IPD-deling Understøttende informationstype

  • SAP

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner